by Alamab | Aug 15, 2019 | ALMB-0166
SUBMISSION OF CLINICAL TRIAL APPLICATION FOR INVESTIGATIONAL FIRST-IN-CLASS NEW DRUG ALMB-0166 IN AUSTRALIA CSPC Pharmaceutical Group Limited 石 藥 集 團 有 限 公 司 (Incorporated in Hong Kong under the Companies Ordinance)(Stock Code: 1093) August 15, 2019 The Board of...
by Alamab | Nov 26, 2018 | ALMB-0166
ALMB-0166 was granted Orphan-Drug Designation by the U.S. FDA CSPC Pharmaceutical Group Limited 石 藥 集 團 有 限 公 司 (Incorporated in Hong Kong under the Companies Ordinance)(Stock Code: 1093) November 26, 2018 The board of directors (the “Board”) of CSPC Pharmaceutical...
by Alamab | Jun 23, 2017 | General
Chinese Pharma Licenses Two Drugs from UT Schools For $4.5 Million Upfront June 23, 2017 San Antonio—A Chinese pharmaceutical company is licensing two experimental drugs from two University of Texas research institutions for an initial $4.5 million upfront payment....
